The global automated cell culture systems market is set for robust expansion, projected to grow at an 8.4% CAGR from 2022 to 2030. The market, valued at USD 10.91 billion in 2022, is expected to reach USD 20.87 billion by the end of the forecast period. This growth is driven by the increasing demand for advanced cell culture technologies in a variety of applications, including stem cell research, drug development, and biopharmaceutical production.
Automated cell culture systems, which currently hold a 44.5% share of the global cell culture market, are revolutionizing biological research and production by improving efficiency, reproducibility, and scalability. These systems are crucial for reducing human error and enhancing throughput, which is critical for sectors like pharmaceuticals, biotech, and clinical research. The rise in stem cell research and the increasing number of drug breakthroughs are key factors driving the need for more sophisticated cell culture technologies.
In addition, there has been a significant increase in investments toward the development of innovative automated cell culture products, which are designed to address the growing complexity of biological systems and the need for high-throughput analysis. As the demand for personalized medicine, gene therapy, and biologics continues to rise, automated systems offer greater precision and efficiency, further accelerating the market’s growth.
Key Takeaways:
- The automated cell culture systems market is expected to grow from USD 10.91 billion in 2022 to USD 20.87 billion by 2030, at an 8.4% CAGR.
- Automated systems currently account for 44.5% of the global cell culture market, driven by their ability to improve efficiency and scalability.
- Rising demand for stem cell research, drug development, and biopharmaceutical production is fueling market expansion.
- Increased investments in innovative product development are driving advancements in automated cell culture technologies.
Competitive Landscape
Manufacturers of automated cell culture systems have been heavily investing in research to develop long-term solutions for both, biopharmaceutical and packaging industries. Sustainable vessel solutions are primarily made up of recyclable plastics and glass bottles.
Recycling, on the other hand, is not without its difficulties. Recycling a multi-layer flexible vessel with barrier material and base material plastic is a time-consuming task.
As a result, companies are actively investing in research aimed at making the recycling process easier. Automated cell culture systems market players are also concentrating on innovations and collaborations to enhance their market presence.
Some of the market players included in this report are Thermo Fisher Scientific, Corning Incorporated, Merck KGaA, Lonza Group Ltd, Sartorius AG, Tecan Trading AG, Hamilton Medical AG, Biospherix, and Promocell GmbH.
Key Companies Profiled
Thermo Fisher Scientific; Corning Incorporated; Merck KGaA; Lonza Group Ltd; Sartorius AG; Tecan Trading AG; Hamilton Medical AG; Biospherix; Promocell GmbH
A Full Report Overview
Key Segments of Automated Cell Culture Systems Industry Survey
Automated Cell Culture Systems Market by Product:
- Automated Cell Culture Storage Equipment
- Automated Cell Culture Vessels
- Bioreactors
- Consumables
Automated Cell Culture Systems Market by Cell Culture:
- Finite Cell Line Cultures
- Infinite Cell Line Cultures
Automated Cell Culture Systems Market by Application:
- Drug Development
- Stem Cell Research
- Regenerative Medicine
- Cancer Research
Automated Cell Culture Systems Market by End User:
- Biotech Companies
- Research Organizations
- Academic Institutes
Automated Cell Culture Systems Market by Region:
- North America Automated Cell Culture Systems Market
- Latin America Automated Cell Culture Systems Market
- Europe Automated Cell Culture Systems Market
- East Asia Automated Cell Culture Systems Market
- South Asia & Pacific Automated Cell Culture Systems Market
- Middle East & Africa (MEA) Automated Cell Culture Systems Market
Author By:
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube